Prospective Randomized Controlled trial of low dose long term Peg-Interferon alpha-2a treatment after curative ablation for Hepatocellular Carcinoma

Authors
Category Primary study
JournalUMIN Clinical Trials Registry
Year 2006
INTERVENTION: Low dose and long term treatment with Peg‐Interferon alpha‐2a Conservertive treatment with drugs like UDCA CONDITION: Chronic hepatitis C Hepatocellular carcinoma PRIMARY OUTCOME: 1. HCC recurent rate; 2. Time to recurrence INCLUSION CRITERIA: 1.Patient with HCC which were curatively treated with RFA. 2.Patient who tried the treatment for eradication of HCV, which was failed. 3.Neutrophil>750/mm3, Platelet, count>50,000, and Hemoglobin>8.5g/dL 4.Patient who was explained about the study, understood it, and gave the consent form.
Epistemonikos ID: eb0b517503d497153830c90cb08383cd13d9ab14
First added on: Aug 21, 2024